flow trial semaglutide renal outcomes 2024 AHA 2024: continues to impress in diabetic kidney disease FLOWing with the SemagluTIDE —

Pre-filled pens, vials with syringes, and newer delivery formats each have nuances

Efficacy of anodal transcranial direct current stimulation is related to sensitivity to transcranial magnetic stimulation

We trained the "intrinsic" models under the hypothesis that removing the pH-dependent component of aqueous solubility would reduce label variance, making the modeling task simpler

The safest approach is alternating nights

Evaluation of waning of SARS-CoV-2 vaccine-induced immunity: a systematic review and meta-analysis

The medicine is evolving quickly, having already expanded to include oral treatments with the first-ever FDA approval for a GLP-1 pill for weight loss for Wegovy at the end of 2025